Search

everythinglearnresearchcommunity

for

Search:↓

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Distinct β-catenin patterns are linked to cell growth, not cell death, in lung cancer.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Live imaging has advanced our understanding of stem cell behavior and raised new research questions.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

The document concludes that veterinary dermatologists need more experience and a better approach to treating skin diseases in nonhuman primates.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.